Search Results - "de Guevara, L Ladrón"

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis by Hirschfield, Gideon M., Bowlus, Christopher L., Mayo, Marlyn J., Kremer, Andreas E., Vierling, John M., Kowdley, Kris V., Levy, Cynthia, Villamil, Alejandra, Ladrón de Guevara Cetina, Alma L., Janczewska, Ewa, Zigmond, Ehud, Jeong, Sook-Hyang, Yilmaz, Yusuf, Kallis, Yiannis, Corpechot, Christophe, Buggisch, Peter, Invernizzi, Pietro, Londoño Hurtado, Maria Carlota, Bergheanu, Sandrin, Yang, Ke, Choi, Yun-Jung, Crittenden, Daria B., McWherter, Charles A.

“…In this trial, the percentage of patients who met the primary end-point criteria (reduction in alkaline phosphatase with normal bilirubin) was significantly…”
Get full text

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis by Lencioni, R, Kudo, M, Ye, S-L, Bronowicki, J-P, Chen, X-P, Dagher, L, Furuse, J, Geschwind, J F, de Guevara, L Ladrón, Papandreou, C, Takayama, T, Yoon, S K, Nakajima, K, Lehr, R, Heldner, S, Sanyal, A J

“…GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma [HCC] and Of its treatment with sorafeNib) is a global, prospective,…”
Get more information

Recovering information in probabilistic quantum teleportation by Roa, Luis, Espinoza, Andrea, Muñoz, Ariana, L. Ladrón de Guevara, María

“…In this paper we redesign the probabilistic teleportation scheme considered in Phys. Rev. A 61, 034301 (2000) by Wan-Li Li et al., where the optimal state…”
Get full text

The second Mexican consensus on hepatocellular carcinoma. Part II: Treatment by Cisneros-Garza, L.E., González-Huezo, M.S., Moctezuma-Velázquez, C., Ladrón de Guevara-Cetina, L., Vilatobá, M., García-Juárez, I., Alvarado-Reyes, R., Álvarez-Treviño, G.A., Allende-Pérez, S., Bornstein-Quevedo, L., Calderillo-Ruiz, G., Carrillo-Martínez, M.A., Castillo-Barradas, M., Cerda-Reyes, E., Félix-Leyva, J.A., Gabutti-Thomas, J.A., Guerrero-Ixtlahuac, J., Higuera-de la Tijera, F., Huitzil-Melendez, D., Kimura-Hayama, E., López-Hernández, P.A., Malé-Velázquez, R., Méndez-Sánchez, N., Morales-Ruiz, M.A., Ruíz-García, E., Sánchez-Ávila, J.F., Torrecillas-Torres, L.

“…Hepatocellular carcinoma (HCC) is more frequently manifesting as one of the main complications of cirrhosis of the liver, its principal risk factor. There have…”
Get full text

The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis by Cisneros-Garza, L.E., González-Huezo, M.S., Moctezuma-Velázquez, C., Ladrón de Guevara-Cetina, L., Vilatobá, M., García-Juárez, I., Alvarado-Reyes, R., Álvarez-Treviño, G.A., Allende-Pérez, S., Bornstein-Quevedo, L., Calderillo-Ruiz, G., Carrillo-Martínez, M.A., Castillo-Barradas, M., Cerda-Reyes, E., Félix-Leyva, J.A., Gabutti-Thomas, J.A., Guerrero-Ixtlahuac, J., Higuera-de-la-Tijera, F., Huitzil-Meléndez, D., Kimura-Hayama, E., López-Hernández, P.A., Malé-Velázquez, R., Méndez-Sánchez, N., Morales-Ruiz, M.A., Ruíz-García, E., Sánchez-Ávila, J.F., Torrecillas-Torres, L.

“…Hepatocellular carcinoma (HCC) is more frequently manifesting as one of the main complications of cirrhosis of the liver, its principal risk factor. There have…”
Get full text

Erradicación de Helicobacter pylori en México con un esquema basado en levofloxacina versus la triple terapia estándar: resultados de un estudio clínico de fase iiib, abierto, aleatorizado, de no inferioridad by Ladrón-de-Guevara, L, Bornstein-Quevedo, L, González-Huezo, S, Castañeda-Romero, B, Costa, F.G, di Silvio-López, M

“…ResumenIntroducción y objetivoLa infección por Helicobacter pylori (H. pylori) representa el factor etiológico más importante en numerosas enfermedades…”
Get full text

Local available quantum correlations by Mundarain, Douglas F., de Guevara, María L. Ladrón

“…In this work, local available quantum correlations are studied. They are defined in terms of mutual information of bipartite local measurements done over an…”
Get full text

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study by Hirschfield, Gideon M, Shiffman, Mitchell L, Gulamhusein, Aliya, Kowdley, Kris V, Vierling, John M, Levy, Cynthia, Kremer, Andreas E, Zigmond, Ehud, Andreone, Pietro, Gordon, Stuart C, Bowlus, Christopher L, Lawitz, Eric J, Aspinall, Richard J, Pratt, Daniel S, Raikhelson, Karina, Gonzalez-Huezo, Maria S, Heneghan, Michael A, Jeong, Sook-Hyang, Ladrón de Guevara, Alma L, Mayo, Marlyn J, Dalekos, George N, Drenth, Joost P H, Janczewska, Ewa, Leggett, Barbara A, Nevens, Frederik, Vargas, Victor, Zuckerman, Eli, Corpechot, Christophe, Fassio, Eduardo, Hinrichsen, Holger, Invernizzi, Pietro, Trivedi, Palak J, Forman, Lisa, Jones, David E J, Ryder, Stephen D, Swain, Mark G, Steinberg, Alexandra, Boudes, Pol F, Choi, Yun-Jung, McWherter, Charles A

“…ENHANCE was a phase 3 study that evaluated efficacy and safety of seladelpar, a selective peroxisome proliferator-activated receptor-δ (PPAR) agonist, versus…”
Get full text

Electronic transport through a parallel-coupled triple quantum dot molecule: Fano resonances and bound states in the continuum by Ladrón de Guevara, M. L., Orellana, P. A.

Get full text

Helicobacter pylori eradication in Mexico with a levofloxacin-based scheme versus standard triple therapy: Results from an open-label, randomized, noninferiority phase iiib trial by Ladrón-de-Guevara, L, Bornstein-Quevedo, L, González-Huezo, S, Castañeda-Romero, B, Costa, F G, di Silvio-López, M

“…Helicobacter pylori (H. pylori) infection remains the leading cause of several gastroduodenal diseases. Despite the fact that multiple antibiotic regimens have…”
Get full text

Transient behavior of pulse propagation in a double-quantum-dot Aharonov–Bohm interferometer by Romo, Roberto, Villavicencio, Jorge, Ladrón de Guevara, M.L.

“…We analyze the transient behavior of a pulse scattered by a double quantum dot Aharonov–Bohm interferometer. Our study uses the analytical solution of the…”
Get full text

P0372 : Gideon: A retrospective analysis of prognostic factors for survival by Bronowicki, J.-P, Kudo, M, Lencioni, R, Chen, X.-P, Dagher, L, Furuse, J, Geschwind, J.-F.H, Ladrón de Guevara, L, Papandreou, C, Sanyal, A.J, Takayama, T, Yoon, S.K, Nakajima, K, Ye, S.-L, Marrero, J.A

Get full text

Helicobacter pylori eradication in Mexico with a levofloxacin-based scheme versus standard triple therapy: Results from an open-label, randomized, noninferiority phase IIIb trial by Ladrón-de-Guevara, L., Bornstein-Quevedo, L., González-Huezo, S., Castañeda-Romero, B., Costa, F.G., di Silvio-López, M.

“…Helicobacter pylori (H. pylori) infection remains the leading cause of several gastroduodenal diseases. Despite the fact that multiple antibiotic regimens have…”
Get full text

The Mexican consensus on nonalcoholic fatty liver disease by Bernal-Reyes, R, Castro-Narro, G, Malé-Velázquez, R, Carmona-Sánchez, R, González-Huezo, M S, García-Juárez, I, Chávez-Tapia, N, Aguilar-Salinas, C, Aiza-Haddad, I, Ballesteros-Amozurrutia, M A, Bosques-Padilla, F, Castillo-Barradas, M, Chávez-Barrera, J A, Cisneros-Garza, L, Flores-Calderón, J, García-Compeán, D, Gutiérrez-Grobe, Y, Higuera de la Tijera, M F, Kershenobich-Stalnikowitz, D, Ladrón de Guevara-Cetina, L, Lizardi-Cervera, J, López-Cossio, J A, Martínez-Vázquez, S, Márquez-Guillén, E, Méndez-Sánchez, N, Moreno-Alcantar, R, Poo-Ramírez, J L, Ramos-Martínez, P, Rodríguez-Hernández, H, Sánchez-Ávila, J F, Stoopen-Rometti, M, Torre-Delgadillo, A, Torres-Villalobos, G, Trejo-Estrada, R, Uribe-Esquivel, M, Velarde-Ruiz Velasco, J A

“…Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk…”
Get full text

Conclusive modification of the overlap between two quantum states by Roa, Luis, de Guevara, M. L. Ladrón, Delgado, A.

“…The task of changing the overlap between two quantum states cannot be performed by making use of unitary evolution only. However, by means of a…”
Get full text

Dicke and Fano effects in single photon transport by Ahumada, Maritza, Cortés, Natalia, Ladrón de Guevara, M.L., Orellana, P.A.

“…The single photon transport through a one dimensional array of cavities is studied theoretically. Analytic expressions of the reflection and transmission are…”
Get full text

Controlling Fano and Dicke effects via a magnetic flux in a two-site Anderson model by ORELLANA, P. A, LADRON DE GUEVARA, M. L, CLARO, F

Get full text

Triple Rashba dots as a spin filter: Bound states in the continuum and Fano effect by Vallejo, M.L., Ladrón de Guevara, M.L., Orellana, P.A.

“…We propose an efficient spin-filter device by exploiting bound states (BICs) in the continuum and Fano effect on a triple Rashba quantum dot molecule embedded…”
Get full text

The Mexican consensus on nonalcoholic fatty liver disease by Bernal-Reyes, R., Castro-Narro, G., Malé-Velázquez, R., Carmona-Sánchez, R., González-Huezo, M.S., García-Juárez, I., Chávez-Tapia, N., Aguilar-Salinas, C., Aiza-Haddad, I., Ballesteros-Amozurrutia, M.A., Bosques-Padilla, F., Castillo-Barradas, M., Chávez-Barrera, J.A., Cisneros-Garza, L., Flores-Calderón, J., García-Compeán, D., Gutiérrez-Grobe, Y., Higuera de la Tijera, M.F., Kershenobich-Stalnikowitz, D., Ladrón de Guevara-Cetina, L., Lizardi-Cervera, J., López-Cossio, J.A., Martínez-Vázquez, S., Márquez-Guillén, E., Méndez-Sánchez, N., Moreno-Alcantar, R., Poo-Ramírez, J.L., Ramos-Martínez, P., Rodríguez-Hernández, H., Sánchez-Ávila, J.F., Stoopen-Rometti, M., Torre-Delgadillo, A., Torres-Villalobos, G., Trejo-Estrada, R., Uribe-Esquivel, M., Velarde-Ruiz Velasco, J.A.

“…Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk…”
Get full text

II Consenso mexicano de carcinoma hepatocelular. Parte II: tratamiento by Cisneros-Garza, L.E., González-Huezo, M.S., Moctezuma-Velázquez, C., Ladrón de Guevara-Cetina, L., Vilatobá, M., García-Juárez, I., Alvarado-Reyes, R., Álvarez-Treviño, G.A., Allende-Pérez, S., Bornstein-Quevedo, L., Calderillo-Ruiz, G., Carrillo-Martínez, M.A., Castillo-Barradas, M., Cerda-Reyes, E., Félix-Leyva, J.A., Gabutti-Thomas, J.A., Guerrero-Ixtlahuac, J., Higuera-de la Tijera, F., Huitzil-Melendez, D., Kimura-Hayama, E., López-Hernández, P.A., Malé-Velázquez, R., Méndez-Sánchez, N., Morales-Ruiz, M.A., Ruíz-García, E., Sánchez-Ávila, J.F., Torrecillas-Torres, L.

“…Resumen: El carcinoma hepatocelular (CHC) se presenta cada vez más frecuentemente como una de las principales complicaciones de cirrosis, su principal factor…”
Get full text